rs121909382
Variant summary
Our verdict is Pathogenic. The variant received 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_001126108.2(SLC12A3):c.1763C>A(p.Ala588Glu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000018 in 1,614,074 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A588V) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001126108.2 missense
Scores
Clinical Significance
Conservation
Publications
- Gitelman syndromeInheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae)
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A3 | NM_001126108.2 | c.1763C>A | p.Ala588Glu | missense_variant | Exon 14 of 26 | ENST00000563236.6 | NP_001119580.2 | |
SLC12A3 | NM_000339.3 | c.1763C>A | p.Ala588Glu | missense_variant | Exon 14 of 26 | NP_000330.3 | ||
SLC12A3 | NM_001126107.2 | c.1760C>A | p.Ala587Glu | missense_variant | Exon 14 of 26 | NP_001119579.2 | ||
SLC12A3 | NM_001410896.1 | c.1760C>A | p.Ala587Glu | missense_variant | Exon 14 of 26 | NP_001397825.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A3 | ENST00000563236.6 | c.1763C>A | p.Ala588Glu | missense_variant | Exon 14 of 26 | 1 | NM_001126108.2 | ENSP00000456149.2 | ||
SLC12A3 | ENST00000438926.6 | c.1763C>A | p.Ala588Glu | missense_variant | Exon 14 of 26 | 1 | ENSP00000402152.2 | |||
SLC12A3 | ENST00000566786.5 | c.1760C>A | p.Ala587Glu | missense_variant | Exon 14 of 26 | 1 | ENSP00000457552.1 | |||
SLC12A3 | ENST00000262502.5 | c.1760C>A | p.Ala587Glu | missense_variant | Exon 14 of 26 | 5 | ENSP00000262502.5 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152228Hom.: 0 Cov.: 33 show subpopulations
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251084 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1461846Hom.: 0 Cov.: 34 AF XY: 0.0000151 AC XY: 11AN XY: 727226 show subpopulations
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152228Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74364 show subpopulations
ClinVar
Submissions by phenotype
Familial hypokalemia-hypomagnesemia Pathogenic:1
- -
not provided Pathogenic:1
This sequence change replaces alanine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 588 of the SLC12A3 protein (p.Ala588Glu). This variant is present in population databases (rs121909382, gnomAD 0.002%). This missense change has been observed in individual(s) with Gitelman syndrome (PMID: 23328711). ClinVar contains an entry for this variant (Variation ID: 2137825). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt SLC12A3 protein function with a positive predictive value of 95%. This variant disrupts the p.Ala588 amino acid residue in SLC12A3. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17329572, 23328711). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at